Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis (Protocol)

William D. Renton, Georgina Tiller, Jane Munro, Joachim Tan, Renea V. Johnston, Jodie C. Avery, Samuel L. Whittle, Anneliese Arno, Rachelle Buchbinder

Research output: Contribution to journalReview ArticleResearchpeer-review

1 Citation (Scopus)


Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of dose reduction or discontinuation of disease-modifying anti-rheumatic drugs in children and young people with clinically inactive juvenile idiopathic arthritis. This is a common protocol for two separate reviews: one on systemic onset juvenile idiopathic arthritis and one on non-systemic juvenile idiopathic arthritis. A secondary objective is to keep the evidence current, using a living systematic review approach.

Original languageEnglish
Article numberCD014961
Number of pages17
JournalCochrane Database of Systematic Reviews
Issue number1
Publication statusPublished - 11 Jan 2022

Cite this